top biopharmaceuticals for glp-1 medication Shortages improve Lilly's weight loss drugs, bumping sales forecast by $3bn 2025 Pharma Trends: Keytruda, Mounjaro,

The results of the ATTAIN-MAINTAIN trial, published May 12 in Nature Medicine, showed that switching to the once-daily orforglipron pill may address this need and help maintain the cardiometabolic benefits

The company has a notable footprint in the GLP-1 agonists market through innovative products that are used for blood glucose control, plus weight management therapies

Wilding JPH et al

Summary table of the three obesity drugs with levers for ease of use, efficacy, and pricing

amycretin Novo Nordisk, which makes Wegovy and Ozempic, is testing this experimental, unimolecular drug to target two hormone pathways, GLP-1 and amylin, a hormone that helps control hunger

Pills vs